EtoBox — Free Books, Journals, and Documents

15 works shown

15 works · 5 duplicate files collapsed

Showing the first matches. Checking the full catalogue…

BOOKS

Books

13 total

Sposa Gitana

Gayle Wilson

2012

EPUB

Giotto

Albert Skira

Giotto

Julia Cartwright

2023

Gambetta

La Gitana

Agatha Christie

Sonata Gitana

Colt

2019

EPUB

SCORES

Sheet music & scores

6 total

Git. 2.mus

Anton Höger

Score

Git. 1.mus

Anton Höger

Score

Gavota

Score

Notatka

Geodeta

Score

Gavota C

Fede

Score

Gavotte G-dur

Score

COMICS MANGA

Comics & manga

1 total

Giotto

cbrit

Read now

DOCUMENTS · SCRIBD

Documents

1 total

Futures at The Threshold: Between Autonomy and Automation: Giota Alevizou Rob Gallagher

ozgur nayir

Read now

RESEARCH ARTICLES

Research articles

11 total

Prós: "The Slow Steady Pace of Ivan Skavinski Skavar": Giota fírcsean

Pádraig Ó Snodaigh

JSTOR2007

DOI 10.2307/25575616

Erratum to “Empirical Bayes and Adjusted Estimates Approach to Estimating the Relation of Mortality to Exposure of PM10,” by Alain Le Tetre, Joel Schwartz, and Giota Touloumi, in Risk Analysis, 25(3), 2005(1)

Springer

Springer2005

DOI 10.1111/j.1539-6924.2005.00701.x

An Giotár

Tomás Ó Canainn

Comhar1998

DOI 10.2307/25573699

Afatinib suivi d’osimertinib en vie réelle chez des patients avec CBNPC avancé EGFR muté : étude GioTag

Hochmair, M.J.

Masson Editeur2019

DOI 10.1016/j.rmr.2018.10.249

Sequential Treatment with Afatinib and Osimertinib in Real-world Patients with EGFR Mutation-positive Advanced NSCLC: the GioTag Study

Hochmair, M.

Elsevier Science2019

DOI 10.1016/s0169-5002(19)30186-2

Afatinib Followed by Osimertinib in Patients with EGFR Mutation-positive Advanced NSCLC: A Real-world Study (GioTag)

Hochmair, M J

Oxford University Press2018

DOI 10.1093/annonc/mdy483.006

OA03 Afatinib Followed by Osimertinib in Real-World Patients with EGFR Mutation-Positive Advanced NSCLC: The Giotag Study

Hochmair, M.J.

Elsevier2018

DOI 10.1016/j.jtho.2018.10.013

Overall Survival in Patients with EGFRm+ NSCLC Receiving Sequential Afatinib and Osimertinib: Updated Analysis of the GioTag Study

Hochmair, M.J.

Oxford University Press2019

DOI 10.1093/annonc/mdz437.015

PD2.05 Overall Survival in Pts with EGFRm+ NSCLC Receiving Sequential Afatinib and Osimertinib: Updated Analysis of the GioTag Study

Hochmair, M.J.

Elsevier2019

DOI 10.1016/j.jtho.2019.09.132

OA03.09 Overall Survival in Patients with EGFRM+ NSCLC Receiving Sequential Afatinib and Osimertinib: an Update of the Giotag Study

Hochmair, M.J.

Elsevier2019

DOI 10.1016/j.jtho.2019.09.039

P1.01-118 Overall Survival in Pts with EGFRm+ NSCLC Receiving Sequential Afatinib and Osimertinib: Updated Analysis of the GioTag Study

Hochmair, M.J.

Elsevier2019

DOI 10.1016/j.jtho.2019.08.833

All matching files

Other editions and formats

Individual editions and file formats that weren't grouped into the works above. Use this when you need a specific format, language, or scan quality.

6 of 20

Giotto

1964

GOLGOTA

Piątek